Ciplite 10 Injection contains Cisplatin 10mg, a highly effective chemotherapeutic agent used in the treatment of multiple cancers including ovarian, testicular, bladder, lung, and head & neck malignancies. It works by interfering with DNA replication in cancer cells, leading to cell death and tumor reduction.
The injectable formulation ensures precise dosing and rapid bioavailability, making it suitable for controlled administration under hospital supervision. Cisplatin is widely used in combination therapy protocols, enhancing treatment efficacy for solid tumors.
For distributors and resellers, Ciplite 10 Injection is a high-demand oncology product, routinely required in cancer hospitals, oncology clinics, chemotherapy units, and specialized healthcare centers. Its critical role in cancer management ensures steady demand and recurring institutional orders.
Adding Ciplite 10 Injection to your portfolio strengthens your oncology and hospital-care segment, providing opportunities for bulk hospital supply, institutional tender orders, private oncology centers, export markets, and third-party manufacturing. Its essential role in chemotherapeutic regimens makes it a profitable and strategically important product for pharmaceutical distributors.